Status:
UNKNOWN
Neolexon® Aphasia-App in Acute Aphasia After Stroke
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Aphasia, Acquired
Stroke, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Up to now there is proven evidence of traditional logopedic therapy in aphasia, but recent computer-based algorithms also showed their evidence so far. Due to small and heterogenous study populations ...
Detailed Description
The prospective, randomized, clinical \& experimental controlled noninvasive study (Lexi) is intended to start in 10/2019. Adult and German speaking patients suffering from aphasia after stroke who gi...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Acute Aphasia after stroke (ischemic oder hemorrhagic)
- Life expectancy ≥ 1 year
- Informed consent (presumed)
- Mother tongue: german
Exclusion
- Age \< 18 years
- Missing aphasia
- Life expectancy \< 1 year
- Mother tongue: other then german
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04080817
Start Date
October 1 2019
End Date
February 1 2020
Last Update
September 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ludwig Maximilians University (LMU) Munich, Department of Neurology with Friedrich-Baur Institute
Munich, Bavaria, Germany, 81377